✦ LIBER ✦

ENHANCED TRANSGENE EXPRESSION IN UROTHELIAL CANCER GENE THERAPY WITH HISTONE DEACETYLASE INHIBITOR

✍ Scribed by OKEGAWA, TAKATSUGU; NUTAHARA, KIKUO; PONG, REY-CHEN; HIGASHIHARA, EIJI; HSIEH, JER-TSONG

Book ID: 122337243
Publisher: Lippincott Williams and Wilkins
Year: 2005
Tongue: English
Weight: 524 KB
Volume: 174
Category: Article
ISSN: 0022-5347
DOI: 10.1097/01.ju.0000164723.20555.e6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced transgene expression in urothel

Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor: Okegawa T, Nutahara K, Pong RC, Higashihara E, Hsieh JT. Department of Urology, University of Kyorin, Tokyo, Japan

✍ Jer-Tsong Hsieh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Changes in histone deacetylase (HDAC) ex

Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers

✍ Niegisch, Günter; Knievel, Judith; Koch, Annemarie; Hader, Christiane; Fischer, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 775 KB

TARGETING NOVEL NUCLEAR RECEPTORS WITH H

TARGETING NOVEL NUCLEAR RECEPTORS WITH HISTONE DEACETYLASE INHIBITOR COMBINATION THERAPY IN BLADDER CANCER

✍ S.A. Abedin; A. Veerakumarasivam; J. Kelly; D.E. Neal; I. Mills; M. Campbell 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 66 KB

491 HDAC (HISTONE DEACETYLASE) EXPRESSIO

491 HDAC (HISTONE DEACETYLASE) EXPRESSION PATTERNS IN UROTHELIAL CANCER AND THEIR IMPACT ON THE ACTION OF HDAC INHIBITORS

✍ G. Niegisch; J. Knievel; A. Koch; P. Albers; W.A. Schulz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Histone deacetylase inhibitors suppress

Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells

✍ William Fazzone; Peter M. Wilson; Melissa J. LaBonte; Heinz-Josef Lenz; Robert D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 532 KB

## Abstract Despite recent therapeutic advances, the response rates to chemotherapy for patients with metastatic colon cancer remain at ∼50% with the fluoropyrimidine, 5‐fluorouracil (5‐FU), continuing to serve as the foundation chemotherapeutic agent for the treatment of this disease. Previous stu

ENHANCED TRANSGENE EXPRESSION IN ANDROGE

ENHANCED TRANSGENE EXPRESSION IN ANDROGEN INDEPENDENT PROSTATE CANCER GENE THERAPY BY TAXANE CHEMOTHERAPEUTIC AGENTS

✍ LI, YINGMING; OKEGAWA, TAKATSUGU; LOMBARDI, DONALD P.; FRENKEL, EUGENE P.; HSIEH 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 838 KB